학술논문
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors
Document Type
Article
Author
Corcoran, R.B.; Kim, J.E.; Parikh, A.R.; Yeku, O.O.; Weekes, C.D.; Ahronian, L.G.; Mauri, G.; Tian, J.; Norden, B.L.; Michel, A.G.; Van Seventer, E.E.; Siravegna, G.; Camphausen, K.; Chi, G.; Fetter, I.J.; Penson, R.T.; Juric, D.; Flaherty, K.T.; Sullivan, R.J.; Clark, J.W.; Heist, R.S.; Do, K.T.; Cleary, J.M.; Veneris, J.; Matulonis, U.A.; Liu, J.F.; Shapiro, G.I.; Xiong, N.; Brugge, J.S.; Chen, H.; Takebe, N.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 1 May 2024, 30(9):1739-1749)
Subject
Language
English
ISSN
15573265
10780432
10780432